Researcher
Patrick Pauwels
- Research Expertise:molecular oncopathology
- Keywords:ANATOMOPATHOLOGY, ONCOLOGY, Medicine
- Disciplines:Oncology not elsewhere classified
- Research techniques:Next gen seq, ddPCR, liquid and tissue biopsy NGS, immunohistochemie, FISH, organoids
- Users of research expertise:researchers in de field of oncology
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Oct 2009 → 31 Dec 2018
Projects
1 - 10 of 32
- RNA Processing for anti-cancer immunotherapy (CANCERNA).From1 Jun 2022 → TodayFunding: HORIZON.2.1 - Health
- Development of an innovative personalised CAR-NK cell therapy for pancreatic cancer.From1 Jan 2022 → TodayFunding: BOF - projects
- A novel photoelectrochemical detection technology for molecular cancer biomarkers.From1 Sep 2021 → 31 Oct 2022Funding: IOF - technology validation in lab
- Combining targeted therapy and immunotherapy to improve survival and quality of life of head and neck cancer patients.From1 Mar 2021 → TodayFunding: Nonprofit institution or equivalents
- Heterogeneity of HER2 amplification in breast cancer – the use of liquid biopsy to identify patients with discrepancies between primary tumor and metastatic lesionsFrom3 Mar 2020 → 2 Mar 2022Funding: Nonprofit institution or equivalents
- Urine as a liquid biopsy for early stage cancer detection.From1 Jan 2020 → 31 Dec 2023Funding: Baekeland
- Integrated Personalized & Precision Oncology Network (IPPON).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- Leveraging patient-driven research to improve rational therapy selection in (ROS1+) non-small cell lung cancer.From1 Jan 2020 → 31 Dec 2021Funding: FWO Humanitarian research project Stand up against Cancer
- Preclinical investigation of immunotherapy and VEGF-targeted therapy in combination with voluntary exercise as novel treatment strategy for malignant pleural mesothelioma.From1 Nov 2019 → TodayFunding: Nonprofit institution or equivalents
- Targeting CD70-positive cancer-associated fibroblasts to improve chemotherapy and alleviate the immuno-suppressive tumor microenvironment in advanced colorectal cancer.From1 Jan 2019 → 31 Dec 2023Funding: Nonprofit institution or equivalents
Publications
11 - 20 of 248
- Comprehensive genomic profiling and therapeutic implications for patients with advanced cancers(2023)
Authors: Laure-Anne Teuwen, Evelyne Roets, Pieter D'Hoore, Patrick Pauwels, Hans Prenen
Pages: 1 - 14 - UAS™(2023)
Authors: Stephanie Jordaens, Amit Arora, Kyle W. MacDonald, Cameron Wood, Jhana Hendrickx, Karen Zwaenepoel, Christophe Deben, Wiebren Tjalma, Patrick Pauwels, Koen Beyers, et al.
Pages: 1 - 15 - NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer(2023)
Authors: Katleen Janssens, Greetje Vanhoutte, Willem Lybaert, Wim Demey, Jochen Decaestecker, Koen Hendrickx, Hassan Rezaei Kalantari, Karen Zwaenepoel, Patrick Pauwels, Erik Fransen, et al.
Pages: 1741 - 1750 - The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy(2023)
Authors: Gizem Öner, Christophe Van Berckelaer, Karen Zwaenepoel, Sevilay Altintas, Zafer Canturk, Wiebren Tjalma, Zwi Berneman, Marc Peeters, Patrick Pauwels, Peter Van Dam
Pages: 17901 - 17913 - OrBITS(2023)
Authors: Christophe Deben, Edgar Cardenas, Maxim Le Compte, Paul Van Schil, Jeroen Hendriks, Suresh Krishnan Yogeswaran, Filip Lardon, Patrick Pauwels, Steven Van Laere, Annemie Bogaerts, et al.
Pages: 299 - 314 - The use of pan-tropomyosin receptor kinase immunohistochemistry as a screening tool for the detection of neurotrophic tropomyosin-related kinase fusions(2022)
Authors: Mieke R. Van Bockstal, Gabriela Beniuga, Ligia Craciun, David Creytens, Franceska Dedeurwaerdere, Philippe Delvenne, Pieter Demetter, Bart De Wiest, Koen Dewinne, Lionel Habran, et al.
Pages: 393 - 406 - Tumor microenvironment in thymic epithelial tumors(2022)
Authors: Apostolos Agrafiotis, Vasiliki Siozopoulou, Jeroen Hendriks, Patrick Pauwels, Senada Koljenovic, Paul Van Schil
Pages: 1 - 11 - Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib(2022)
Authors: Ahmad Awada, Thierry Berghmans, Paul M. Clement, Kristof Cuppens, Bram De Wilde, Jean-Pascal Machiels, Patrick Pauwels, Marc Peeters, Sylvie Rottey, Eric Van Cutsem
- A case report of a novel NTRK gene fusion in pleomorphic xanthoastrocytoma(2022)
Authors: Melek Ahmed, Joris Verlooy, An-Sofie Schoonjans, Sven Dekeyzer, Martin Lammens, Patrick Pauwels
Pages: 233 - 235 - Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era(2022)
Authors: Jaume Capdevila, Ahmad Awada, Dagmar Fuehrer-Sakel, Sophie Leboulleux, Patrick Pauwels
Pages: 1 - 11
Patents
1 - 4 of 4
- Immunotherapy markers (Inventor)
- Cell-based therapeutics targeting CD70 (Inventor)
- Immunotherapy markers (Inventor)
- Immunotherapy Markers (Inventor)